Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1998 Aug;53(Suppl 2):S15–S19. doi: 10.1136/thx.53.2008.s15

Update on the "Dutch hypothesis" for chronic respiratory disease

J Vestbo, E Prescott
PMCID: PMC1765904  PMID: 10193342

Full Text

The Full Text of this article is available as a PDF (92.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anthonisen N. R., Connett J. E., Kiley J. P., Altose M. D., Bailey W. C., Buist A. S., Conway W. A., Jr, Enright P. L., Kanner R. E., O'Hara P. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA. 1994 Nov 16;272(19):1497–1505. [PubMed] [Google Scholar]
  2. Bakke P. S., Baste V., Gulsvik A. Bronchial responsiveness in a Norwegian community. Am Rev Respir Dis. 1991 Feb;143(2):317–322. doi: 10.1164/ajrccm/143.2.317. [DOI] [PubMed] [Google Scholar]
  3. Barker D. J., Godfrey K. M., Fall C., Osmond C., Winter P. D., Shaheen S. O. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ. 1991 Sep 21;303(6804):671–675. doi: 10.1136/bmj.303.6804.671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Britton J., Martinez F. D. The relationship of childhood respiratory infection to growth and decline in lung function. Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 2):S240–S245. doi: 10.1164/ajrccm/154.6_Pt_2.S240. [DOI] [PubMed] [Google Scholar]
  5. Du Toit J. I., Woolcock A. J., Salome C. M., Sundrum R., Black J. L. Characteristics of bronchial hyperresponsiveness in smokers with chronic air-flow limitation. Am Rev Respir Dis. 1986 Sep;134(3):498–501. doi: 10.1164/arrd.1986.134.3.498. [DOI] [PubMed] [Google Scholar]
  6. Gold D. R., Wang X., Wypij D., Speizer F. E., Ware J. H., Dockery D. W. Effects of cigarette smoking on lung function in adolescent boys and girls. N Engl J Med. 1996 Sep 26;335(13):931–937. doi: 10.1056/NEJM199609263351304. [DOI] [PubMed] [Google Scholar]
  7. Higgins B. G., Britton J. R., Chinn S., Jones T. D., Vathenen A. S., Burney P. G., Tattersfield A. E. Comparison of histamine and methacholine for use in bronchial challenge tests in community studies. Thorax. 1988 Aug;43(8):605–610. doi: 10.1136/thx.43.8.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kelly W. J., Hudson I., Raven J., Phelan P. D., Pain M. C., Olinsky A. Childhood asthma and adult lung function. Am Rev Respir Dis. 1988 Jul;138(1):26–30. doi: 10.1164/ajrccm/138.1.26. [DOI] [PubMed] [Google Scholar]
  9. Kerstjens H. A., Rijcken B., Schouten J. P., Postma D. S. Decline of FEV1 by age and smoking status: facts, figures, and fallacies. Thorax. 1997 Sep;52(9):820–827. doi: 10.1136/thx.52.9.820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lange P., Ulrik C. S., Vestbo J. Mortality in adults with self-reported asthma. Copenhagen City Heart Study Group. Lancet. 1996 May 11;347(9011):1285–1289. doi: 10.1016/s0140-6736(96)90937-x. [DOI] [PubMed] [Google Scholar]
  11. Leynaert B., Bousquet J., Henry C., Liard R., Neukirch F. Is bronchial hyperresponsiveness more frequent in women than in men? A population-based study. Am J Respir Crit Care Med. 1997 Nov;156(5):1413–1420. doi: 10.1164/ajrccm.156.5.9701060. [DOI] [PubMed] [Google Scholar]
  12. O'Connor G. T., Sparrow D., Weiss S. T. A prospective longitudinal study of methacholine airway responsiveness as a predictor of pulmonary-function decline: the Normative Aging Study. Am J Respir Crit Care Med. 1995 Jul;152(1):87–92. doi: 10.1164/ajrccm.152.1.7599868. [DOI] [PubMed] [Google Scholar]
  13. O'Connor G. T., Sparrow D., Weiss S. T. The role of allergy and nonspecific airway hyperresponsiveness in the pathogenesis of chronic obstructive pulmonary disease. Am Rev Respir Dis. 1989 Jul;140(1):225–252. doi: 10.1164/ajrccm/140.1.225. [DOI] [PubMed] [Google Scholar]
  14. Parker D. R., O'Connor G. T., Sparrow D., Segal M. R., Weiss S. T. The relationship of nonspecific airway responsiveness and atopy to the rate of decline of lung function. The Normative Aging Study. Am Rev Respir Dis. 1990 Mar;141(3):589–594. doi: 10.1164/ajrccm/141.3.589. [DOI] [PubMed] [Google Scholar]
  15. Peat J. K., Salome C. M., Xuan W. On adjusting measurements of airway responsiveness for lung size and airway caliber. Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):870–875. doi: 10.1164/ajrccm.154.4.8887577. [DOI] [PubMed] [Google Scholar]
  16. Peat J. K., Woolcock A. J., Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis. 1987 Mar;70(3):171–179. [PubMed] [Google Scholar]
  17. Peat J. K., Woolcock A. J., Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis. 1987 Mar;70(3):171–179. [PubMed] [Google Scholar]
  18. Prescott E., Bjerg A. M., Andersen P. K., Lange P., Vestbo J. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J. 1997 Apr;10(4):822–827. [PubMed] [Google Scholar]
  19. Rijcken B., Schouten J. P., Rosner B., Weiss S. T. Is it useful to distinguish between asthma and chronic obstructive pulmonary disease in respiratory epidemiology. Am Rev Respir Dis. 1991 Jun;143(6):1456–1457. doi: 10.1164/ajrccm/143.6.1456. [DOI] [PubMed] [Google Scholar]
  20. Rijcken B., Schouten J. P., Weiss S. T., Speizer F. E., van der Lende R. The relationship between airway responsiveness to histamine and pulmonary function level in a random population sample. Am Rev Respir Dis. 1988 Apr;137(4):826–832. doi: 10.1164/ajrccm/137.4.826. [DOI] [PubMed] [Google Scholar]
  21. Rijcken B., Schouten J. P., Xu X., Rosner B., Weiss S. T. Airway hyperresponsiveness to histamine associated with accelerated decline in FEV1. Am J Respir Crit Care Med. 1995 May;151(5):1377–1382. doi: 10.1164/ajrccm.151.5.7735588. [DOI] [PubMed] [Google Scholar]
  22. Rijcken B., Weiss S. T. Longitudinal analyses of airway responsiveness and pulmonary function decline. Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 2):S246–S249. doi: 10.1164/ajrccm/154.6_Pt_2.S246. [DOI] [PubMed] [Google Scholar]
  23. Saetta M., Finkelstein R., Cosio M. G. Morphological and cellular basis for airflow limitation in smokers. Eur Respir J. 1994 Aug;7(8):1505–1515. doi: 10.1183/09031936.94.07081505. [DOI] [PubMed] [Google Scholar]
  24. Sparrow D., O'Connor G., Colton T., Barry C. L., Weiss S. T. The relationship of nonspecific bronchial responsiveness to the occurrence of respiratory symptoms and decreased levels of pulmonary function. The Normative Aging Study. Am Rev Respir Dis. 1987 Jun;135(6):1255–1260. doi: 10.1164/arrd.1987.135.6.1255. [DOI] [PubMed] [Google Scholar]
  25. Stein C. E., Kumaran K., Fall C. H., Shaheen S. O., Osmond C., Barker D. J. Relation of fetal growth to adult lung function in south India. Thorax. 1997 Oct;52(10):895–899. doi: 10.1136/thx.52.10.895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Tager I. B., Segal M. R., Speizer F. E., Weiss S. T. The natural history of forced expiratory volumes. Effect of cigarette smoking and respiratory symptoms. Am Rev Respir Dis. 1988 Oct;138(4):837–849. doi: 10.1164/ajrccm/138.4.837. [DOI] [PubMed] [Google Scholar]
  27. Tashkin D. P., Altose M. D., Bleecker E. R., Connett J. E., Kanner R. E., Lee W. W., Wise R. The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research Group. Am Rev Respir Dis. 1992 Feb;145(2 Pt 1):301–310. doi: 10.1164/ajrccm/145.2_Pt_1.301. [DOI] [PubMed] [Google Scholar]
  28. Tashkin D. P., Altose M. D., Connett J. E., Kanner R. E., Lee W. W., Wise R. A. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med. 1996 Jun;153(6 Pt 1):1802–1811. doi: 10.1164/ajrccm.153.6.8665038. [DOI] [PubMed] [Google Scholar]
  29. Tracey M., Villar A., Dow L., Coggon D., Lampe F. C., Holgate S. T. The influence of increased bronchial responsiveness, atopy, and serum IgE on decline in FEV1. A longitudinal study in the elderly. Am J Respir Crit Care Med. 1995 Mar;151(3 Pt 1):656–662. doi: 10.1164/ajrccm/151.3_Pt_1.656. [DOI] [PubMed] [Google Scholar]
  30. Vestbo J., Prescott E., Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med. 1996 May;153(5):1530–1535. doi: 10.1164/ajrccm.153.5.8630597. [DOI] [PubMed] [Google Scholar]
  31. Woolcock A. J., Peat J. K., Salome C. M., Yan K., Anderson S. D., Schoeffel R. E., McCowage G., Killalea T. Prevalence of bronchial hyperresponsiveness and asthma in a rural adult population. Thorax. 1987 May;42(5):361–368. doi: 10.1136/thx.42.5.361. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES